Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR …
M Jary, W Liu, D Yan, I Bai, A Muranyi… - Molecular …, 2022 - Wiley Online Library
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, W Liu, D Yan, I Bai, A Muranyi, E Colle… - Molecular …, 2021 - hal.science
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
[HTML][HTML] Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, WW Liu, D Yan, I Bai, A Muranyi… - Molecular …, 2022 - ncbi.nlm.nih.gov
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, W Liu, D Yan, I Bai, A Muranyi, E Colle… - Molecular …, 2021 - inria.hal.science
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR …
M Jary, WW Liu, D Yan, I Bai, A Muranyi, E Colle… - 2022 - pubmed.ncbi.nlm.nih.gov
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, W Liu, D Yan, I Bai, A Muranyi… - Molecular …, 2021 - hal.sorbonne-universite.fr
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, W Liu, D Yan, I Bai, A Muranyi, E Colle… - Molecular …, 2021 - uca.hal.science
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR …
M Jary, WW Liu, D Yan, I Bai, A Muranyi… - Molecular …, 2022 - search.proquest.com
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR …
M Jary, WW Liu, D Yan, I Bai, A Muranyi, E Colle… - Molecular …, 2022 - europepmc.org
In the era of immune checkpoint inhibitors, understanding the metastatic microenvironment
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
of proficient mismatch repair/microsatellite stable (pMMR/MSS) colorectal cancer (CRC) is of …
[PDF][PDF] The immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX …
M Jary, W Liu, D Yan, I Bai, A Muranyi… - Molecular …, 1878 - hal.sorbonne-universite.fr
3 ABSTRACT 4 In the era of immune checkpoint inhibitors, understanding the metastatic
microenvironment of 5 proficient mismatch repair/microsatellite stable (pMMR/MSS) …
microenvironment of 5 proficient mismatch repair/microsatellite stable (pMMR/MSS) …